Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 8.06 4.00% 0.31
SRNE closed up 4.0 percent on Friday, July 10, 2020, on 76 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical SRNE trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 4.00%
Wide Bands Range Expansion 4.00%
Overbought Stochastic Strength 4.00%
Upper Bollinger Band Walk Strength 10.56%
Inside Day Range Contraction 10.56%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Medicine Biotechnology Biopharmaceutical Health Cancer Biology Immunology Disease Infectious Diseases Treatment Of Cancer Immune System Inflammation Antibody Monoclonal Antibody Antibody Therapy

Is SRNE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.0
52 Week Low 1.39
Average Volume 40,424,425
200-Day Moving Average 3.16
50-Day Moving Average 4.88
20-Day Moving Average 6.02
10-Day Moving Average 6.97
Average True Range 0.62
ADX 47.54
+DI 45.19
-DI 8.16
Chandelier Exit (Long, 3 ATRs ) 6.66
Chandelier Exit (Short, 3 ATRs ) 6.16
Upper Bollinger Band 8.26
Lower Bollinger Band 3.78
Percent B (%b) 0.96
BandWidth 74.45
MACD Line 0.85
MACD Signal Line 0.67
MACD Histogram 0.1773
Fundamentals Value
Market Cap 555.9 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -12.25
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.08
Resistance 3 (R3) 9.12 8.81 8.91
Resistance 2 (R2) 8.81 8.55 8.80 8.85
Resistance 1 (R1) 8.44 8.39 8.63 8.40 8.80
Pivot Point 8.13 8.13 8.23 8.12 8.13
Support 1 (S1) 7.76 7.87 7.95 7.72 7.32
Support 2 (S2) 7.45 7.71 7.44 7.27
Support 3 (S3) 7.08 7.45 7.21
Support 4 (S4) 7.04